Skip to Main Content

If a prescription drug needs a hard sell, can it really be all that good?

A new analysis suggests the answer is no, at least in Canada.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • There is a reason why drug reps do not promote the drugs on the WHO EML. All of the meds on the list from what I can see are generic. With the typical pharma company paying $3000 or more a day for one rep to visit 10 docs it it doesn’t make sense for them to be pushing generics. One also might argue the definition of “essential”. For example there are no TNF inhibitors on the list for rheumatoid arthritis, just the ones I learned about when I took pharmacology 45 years ago.

Comments are closed.